In this Opinions piece, Clerkenwell Health’s Arda Ozcubukcu discusses the potential value that could be derived from a greater focus on the use of evidence-based psychotherapies in psychedelic research and practice. Below, Arda shares how such an approach may support efforts to prove cost-effectiveness, enable psychedelics to be more easily integrated into existing systems, and more.
